This product can be used for the following infections caused by bacteria sensitive to cefuroxime:
1. Respiratory tract infections: Respiratory tract infections caused by Streptococcus pneumoniae, Haemophilus influenzae (containing ampicillin resistant bacteria), Klebsiella pneumoniae, Staphylococcus aureus (penicillin producing and non penicillin producing bacteria), Streptococcus pyogenes, and Escherichia coli, such as acute and chronic bronchitis, coexisting infections with bronchiectasis, bacterial pneumonia, lung abscess, and postoperative lung infections.
2. Otolaryngology infections: otitis media, sinusitis, tonsillitis, pharyngitis.
3. Urinary tract infection: Urinary tract infection caused by Escherichia coli and Klebsiella bacteria, such as acute and chronic pyelonephritis, cystitis, and asymptomatic bacteriuria.
4. Skin and soft tissue infections: Skin and soft tissue infections caused by Staphylococcus aureus (penicillin enzyme producing and non penicillin enzyme producing bacteria), Streptococcus pyogenes, Escherichia coli, Klebsiella and Enterobacteriaceae, such as cellulitis, erysipelas, peritonitis, and trauma infections.
5. Septicemia: Septicemia caused by Staphylococcus aureus (penicillin producing and non penicillin producing bacteria), Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae (including ampicillin resistant bacteria), and Klebsiella pneumoniae bacteria.
6. Meningitis: Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (containing ampicillin resistant bacteria), Neisseria meningitidis, and Staphylococcus aureus (penicillin enzyme producing and non penicillin enzyme producing bacteria).
7. Gonorrhea: Simple (uncomplicated) and comorbid gonorrhea caused by Neisseria gonorrhoeae (penicillin producing and non penicillin producing bacteria), especially suitable for those who are not suitable for penicillin treatment.
8. Bone and joint infections: Bone and joint infections caused by Staphylococcus aureus (penicillin enzyme producing bacteria and non penicillin enzyme producing bacteria).
This product can also be used before or during surgery to prevent the growth of sensitive pathogens and reduce infections caused by contamination during and after surgery. Prevention of infection in abdominal, pelvic, and orthopedic surgeries, heart, lung, esophageal and vascular surgeries, and total joint replacement surgeries.
1,Reyoung Pharmaceutical Co., Ltd., established in 1966, is one of the leading manufacturer and distributor of pharmaceutical products in China. Reyoung Pharma is an GMP, ISO9001, ISO14001, OHS18001 authentication enterprise and so on. The trademark "REYOUNG" is famous trademark of China.
Reyoung Pharma has three main factories which covers an area of 1,000,000 square meters and owns total asset of more than 1.5 billion USD dollar. There is more than 5000 staff in Reyoung Pharma, of whom approximate 21 percent of the total staff is sales & marketing personnel. Reyoung Pharma has 30 workshops that can produce ten categories and more than 400 specifications of pharmaceutical products including tablets, capsules, granules, sterile active ingredients, small volume injection, powder for injection, lyophilized powder for injection, suppository, traditional Chinese medicine and aerosol. The annual production capacity can reach 2.5 billion vials of powder for injection, 300 million ampoules of liquid injection, 4 billion tablets, 6 billion capsules and 200 million bags granule of solid formulation, and 2000 tons API respectively. As a professional pharmaceutical manufacturer, Reyoung Pharma is the first enterprise to manufacture powder for injection in Shandong province. The sales and marketing network for its products covers all the big and medium cities through the mainland of PRC and also has been successfully covered more than 70 countries all over the world. In order to praise Reyoung Pharma making so much contribution to Chinese pharmaceutical industry, the government granted many awards and certifications, such as state-focused high & new tech enterprise of China, national contract-stressing and promise-keeping enterprise of China, the production base of cephalosporin raw material, advanced Collective of pharmaceutical industry of Shandong province and so on.
2,Reyoung Pharma commenced international business and exported products in 1997. Reyoung Pharma, with an excellent sales&documentation team, owned over 20 years experience in the international transaction and registered products in different countries. Reyoung Pharma has passed the GMP inspection of Colombia, Peru, Congo, Ethiopia, Uganda, Nigeria, Ghana, Tanzania, Kenya, Cote d'Ivoire, Pakistan, Ukraine, Philippines, Cambodia, etc. Products have been exported to Asia, South America, Africa, CIS Countries, Middle East and Europe including Thailand, Philippines, Cambodia, Hong Kong, Vietnam, India, Pakistan, Colombia, Peru, Chile, Costa Rica, Venezuela, Congo, Ethiopia, Uganda, Nigeria, Tanzania, Kenya, Cameroon, Russia, Kazakhstan, Ukraine, Uzbekistan, Georgia, Yemen, Iraq, Germany, Denmark, and so on.
Audited Supplier 
){kind=link}